Insulin Effects on Cardiac Function in Patients With Diabetes Mellitus
NCT02962921 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2016-11-15
Summary
Our investigation studies the role of acute insulin administration on the diabetic heart, its corresponding effective blood-insulin level and the time-course applicability of insulin in a routine clinical setting.
A case series of six male (48.1 ± 4.9 y/o) patients with controlled diabetes (HbA1c of 6.6 ± 0.3%, disease duration of 14.4 ± 6.7 yr). Each subject was evaluated for glucose homeostatic, hemodynamic and echocardiographic systolic and diastolic parameters at baseline and following two successive insulin-load steps of a euglycemic hyperinsulinemic clamp study, each 2 h in duration. Results are presented as a mean ± SEM and analysed using the student's t-test.
Conditions
- Diabetes Mellitus
- Ventricular Dysfunction
Interventions
- DRUG
-
Insulin LISPRO intravenous loading
intravenous infusion of insulin Lispro.
Sponsors & Collaborators
-
Rambam Health Care Campus
lead OTHER
Principal Investigators
-
Eddy Karnieli, MD · Professor emeritus, Faculty of medicine, Technion. Haifa, Israel
-
Ronen Bar Yoseph, MD · Pediatric Pulmonary Institute
-
Sergey Yalonetsky, MD · Cardiology Division
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 30 Years
- Max Age
- 65 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-02-28
- Primary Completion
- 2003-05-31
- Completion
- 2004-11-30
Countries
- Israel
Study Locations
More Related Trials
-
Glucagon's Cardiovascular Effects With and Without Beta-blocker-induced Cardioinhibition
NCT03533179 ·Status: COMPLETED ·Phase: PHASE4
-
Plasma Glucagon-like Peptide-1 Levels and Acute Myocardial Infarction
NCT03129594 ·Status: COMPLETED
-
Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance
NCT03383822 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Diastolic RV EvAluation With Millar Catheter to Investigate the Effect of Glucagon-Like Peptide-1 (GLP-1) on Right Ventricular Function During Elective Coronary Angioplasty and Stenting
NCT02236299 ·Status: UNKNOWN ·Phase: NA
-
Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin
NCT04034524 ·Status: UNKNOWN
-
Insulin Therapy in Type 2 Diabetic Patients: Real-life Study on Effectiveness and Satisfaction
NCT06117449 ·Status: NOT_YET_RECRUITING
-
Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes
NCT01206322 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.
NCT01931982 ·Status: COMPLETED ·Phase: PHASE4
-
Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis
NCT02602600 ·Status: COMPLETED ·Phase: PHASE4
-
GLP-1 Analogue Treatment in Uncontrolled Type 1 Diabetic Patients
NCT01592279 ·Status: UNKNOWN ·Phase: PHASE4
-
Studies of Insulin and Glucagon Action in the Liver
NCT07300982 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM
NCT04965051 ·Status: UNKNOWN ·Phase: NA
-
Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes
NCT03356457 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes
NCT01021865 ·Status: COMPLETED
-
"Effect of Central Insulin Administration on Whole-body Insulin Sensitivity in Women"
NCT03929419 ·Status: COMPLETED ·Phase: NA
-
Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes
NCT00562133 ·Status: COMPLETED ·Phase: PHASE3
-
Modulation of Human Myocardial Metabolism by GLP-1 Dose Response
NCT01607450 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prevention of Postprandial Hyperglycemia by Acarbose May be a Promising Therapeutic Strategy for Reducing the Increased Risk for Cardiovascular Disease
NCT01167231 ·Status: COMPLETED
-
Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus
NCT01299012 ·Status: COMPLETED
-
Clinical Study of Liraglutide in Improving Cardiac Function for Patients With Ischemic Cardiomyopathy
NCT02930265 ·Status: UNKNOWN ·Phase: NA
-
Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients
NCT05360537 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Intranasal Insulin on Hepatic and Intestinal Triglyceride-rich Lipoprotein Production
NCT03141827 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of Metformin Treatment on Myocardial Efficiency in Patients With Heart Failure
NCT02810132 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes Mellitus
NCT01472640 ·Status: COMPLETED ·Phase: NA
-
Tight Glycemic Control Increases Cardiac Stem Cells During Acute Myocardial Infarction
NCT00863629 ·Status: COMPLETED ·Phase: PHASE4